EP1333862A4 - Verfahren und pharmazeutische zusammensetzungen zur verbesserung der implantation von embryos - Google Patents

Verfahren und pharmazeutische zusammensetzungen zur verbesserung der implantation von embryos

Info

Publication number
EP1333862A4
EP1333862A4 EP01978796A EP01978796A EP1333862A4 EP 1333862 A4 EP1333862 A4 EP 1333862A4 EP 01978796 A EP01978796 A EP 01978796A EP 01978796 A EP01978796 A EP 01978796A EP 1333862 A4 EP1333862 A4 EP 1333862A4
Authority
EP
European Patent Office
Prior art keywords
embryos
methods
pharmaceutical compositions
improving implantation
implantation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01978796A
Other languages
English (en)
French (fr)
Other versions
EP1333862A2 (de
Inventor
Oron Yacoby-Zeevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Biopharmaceuticals Ltd
Original Assignee
Insight Strategy and Marketing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Strategy and Marketing Ltd filed Critical Insight Strategy and Marketing Ltd
Publication of EP1333862A2 publication Critical patent/EP1333862A2/de
Publication of EP1333862A4 publication Critical patent/EP1333862A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01978796A 2000-10-17 2001-10-15 Verfahren und pharmazeutische zusammensetzungen zur verbesserung der implantation von embryos Withdrawn EP1333862A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24085700P 2000-10-17 2000-10-17
US240857P 2000-10-17
PCT/IL2001/000950 WO2002032283A2 (en) 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos

Publications (2)

Publication Number Publication Date
EP1333862A2 EP1333862A2 (de) 2003-08-13
EP1333862A4 true EP1333862A4 (de) 2004-08-18

Family

ID=22908221

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01978796A Withdrawn EP1333862A4 (de) 2000-10-17 2001-10-15 Verfahren und pharmazeutische zusammensetzungen zur verbesserung der implantation von embryos

Country Status (3)

Country Link
EP (1) EP1333862A4 (de)
AU (1) AU2002210887A1 (de)
WO (1) WO2002032283A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20040033218A1 (en) * 2000-12-19 2004-02-19 Oron Yacoby-Zeevi Use of ecm degrading enzymes for the improvement of cell transplantation
CN100384481C (zh) * 2004-11-03 2008-04-30 上海市计划生育科学研究所 胚泡着床相关因子及其用途
CN100415299C (zh) * 2004-12-22 2008-09-03 上海市计划生育科学研究所 胚泡着床相关因子及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002977A1 (en) * 1989-08-23 1991-03-07 Hadassah Medical Organization Wound healing preparations containing heparanase
WO1999011798A1 (en) * 1997-09-02 1999-03-11 Insight Strategy & Marketing Ltd. Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
WO1999021975A1 (en) * 1997-10-28 1999-05-06 The Australian National University Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
WO2000052149A1 (en) * 1999-03-02 2000-09-08 Insight Strategy & Marketing Ltd. Introducing a biological material into a patient

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002977A1 (en) * 1989-08-23 1991-03-07 Hadassah Medical Organization Wound healing preparations containing heparanase
US5362641A (en) * 1989-08-23 1994-11-08 Hadassah Medical Organization Kiryat Hadassah Heparanase derived from human Sk-Hep-1 cell line
WO1999011798A1 (en) * 1997-09-02 1999-03-11 Insight Strategy & Marketing Ltd. Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
WO1999021975A1 (en) * 1997-10-28 1999-05-06 The Australian National University Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
WO2000052149A1 (en) * 1999-03-02 2000-09-08 Insight Strategy & Marketing Ltd. Introducing a biological material into a patient

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CARSON DANIEL D ET AL: "Mucin and proteoglycan functions in embryo implantation", BIOESSAYS, vol. 20, no. 7, July 1998 (1998-07-01), pages 577 - 583, XP002284179, ISSN: 0265-9247 *
DEMPSEY L A ET AL: "Heparanase expression in invasive trophoblasts and acute vascular damage", GLYCOBIOLOGY, IRL PRESS,, GB, vol. 10, no. 5, May 2000 (2000-05-01), pages 467 - 475, XP002232893, ISSN: 0959-6658 *
DEMPSEY L A ET AL: "Heparanase, a potential regulator of cell-matrix interactions.", TRENDS IN BIOCHEMICAL SCIENCES. ENGLAND AUG 2000, vol. 25, no. 8, August 2000 (2000-08-01), pages 349 - 351, XP004215172, ISSN: 0968-0004 *
VLODAVSKY I ET AL: "EXPRESSION OF HEPARANASE BY PLATELETS AND CIRCULATING CELLS OF THE IMMUNE SYSTEM: POSSIBLE INVOLVEMENT IN DIAPEDESIS AND EXTRAVASATION", INVASION METASTASIS, S. KARGER, BASEL, CH, vol. 12, no. 2, March 1992 (1992-03-01), pages 112 - 127, XP001106180, ISSN: 0251-1789 *

Also Published As

Publication number Publication date
WO2002032283A3 (en) 2002-10-31
EP1333862A2 (de) 2003-08-13
WO2002032283A2 (en) 2002-04-25
AU2002210887A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
AU5160201A (en) Compositions comprising natural agents for treatment of cancer
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
EP1461047A4 (de) Zusammensetzungen und verfahren zur behandlung von tieren
EP1333825A4 (de) Methoden zur verbesserten zuführung von oxybutynin und zusammensetzungen hieraus
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
IL153687A0 (en) Composition and method for enhancing elasticity of tissue
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
EP1075184A4 (de) Zusammensetzungen und verfahren zur aktiven impfung
HUP0300860A3 (en) Pharmaceutical compositions suitable for treatment of urinary dysfunction
HUP0303178A3 (en) Methods and compositions for reducing the taste of pharmaceutically active agents
IL153487A0 (en) Pharmaceutical compositions and methods for use
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
IL153897A0 (en) Pharmaceutical compositions and methods for use
EP1333862A4 (de) Verfahren und pharmazeutische zusammensetzungen zur verbesserung der implantation von embryos
AU3712500A (en) Compositions and methods for treatment of epilepsy
GB2378135B (en) Compositions derived from modiolus modiolus and methods for making and using same
HUP0200466A3 (en) Lipoglycan compositions and methods of treating parasitic infections
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
IL130556A0 (en) Synergistic compositions for treatment of liver diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030513

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07H 21/04 B

Ipc: 7C 07H 21/02 B

Ipc: 7C 12N 15/86 B

Ipc: 7C 12N 15/85 B

Ipc: 7C 12N 15/11 B

Ipc: 7A 61K 38/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040701

17Q First examination report despatched

Effective date: 20050329

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INSIGHT BIOPHARMACEUTICALS LTD.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080411